TRCT
AIFF

Tower Research Capital (TRC)’s Firefly Neuroscience AIFF Stock Holding History

Tower Research Capital (TRC)’s Portfolio AIFF Stock Details AIFF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.96K Buy
2,732
+70
+3% +$87 ﹤0.01% 4087
2025
Q4 		$2.33K Buy
2,662
+446
+20% +$832 ﹤0.01% 4551
2025
Q3 		$6.45K Sell
2,216
-860
-28% -$2.44K ﹤0.01% 4160
2025
Q2 		$8.71K Buy
3,076
+1,567
+104% +$4.97K ﹤0.01% 4012
2025
Q1 		$5.93K Sell
1,509
-281
-16% -$1.29K ﹤0.01% 4078
2024
Q4 		$4.74K Buy
1,790
+486
+37% +$1.51K ﹤0.01% 4405
2024
Q3 		$3.96K Buy
1,304
+257
+25% +$1.35K ﹤0.01% 4720
2024
Q2 		$6.5K Buy
1,047
+571
+120% +$4.25K ﹤0.01% 4571
2024
Q1 		$4.94K Sell
476
-1,777
-79% -$11.9K ﹤0.01% 4610
2023
Q4 		$11.4K Buy
2,253
+1,991
+760% +$12.9K ﹤0.01% 4132
2023
Q3 		$2.04K Hold
262
– – ﹤0.01% 5226
2023
Q2 		$2.4K Sell
262
-3
-1% -$34 ﹤0.01% 5206
2023
Q1 		$2K Buy
265
+3
+1% +$59 ﹤0.01% 5418
2022
Q4 		$4K Sell
262
-40
-13% -$931 ﹤0.01% 5088
2022
Q3 		$8K Buy
302
+147
+95% +$5.39K ﹤0.01% 4822
2022
Q2 		$6K Sell
155
-132
-46% -$12.7K ﹤0.01% 4968
2022
Q1 		$46K Buy
+287
New +$38.8K ﹤0.01% 2811

Other funds holding AIFF

Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SRL
Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Tower Research Capital (TRC)'s AIFF Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Firefly Neuroscience (AIFF) stake by 2.6% in Q1 2026, buying an estimated $87 and bringing the position to 2,732 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #4087.

Tower Research Capital (TRC) first reported a position in AIFF in Q1 2022 and has held it in 17 quarters since. The position peaked at $46K in Q1 2022. 23 funds tracked by Wall St. Rank hold AIFF as of Q1 2026.

  • Tower Research Capital (TRC) held 2,732 shares of Firefly Neuroscience worth $5.96K as of Q1 2026.
  • Tower Research Capital (TRC) bought 70 Firefly Neuroscience shares in Q1 2026, an estimated $87.
  • Firefly Neuroscience made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4087 holding.
  • Tower Research Capital (TRC) first reported a position in Firefly Neuroscience in Q1 2022 and has held it in 17 quarters since.
  • Tower Research Capital (TRC)'s Firefly Neuroscience position peaked at $46K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.